Skip to content

Bone Density in Patients With Schizophrenia

Bone Mineral Density in the Korean Patients With Chronic Schizophrenia With Alcohol Abuse

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00540267
Enrollment
300
Registered
2007-10-05
Start date
2007-11-30
Completion date
2008-11-30
Last updated
2008-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Abuse, Schizophrenia

Keywords

Schizophrenia, Alcohol Abuse, Bone Density

Brief summary

People with chronic mental disorder such as schizophrenia and alcohol abuse are high risk groups for developing osteoporosis. To evaluate the prevalence of bone mineral density in men patients with schizophrenia with alcohol abuse, the investigators will compare bone mineral density between patient with schizophrenia with and without alcohol abuse.

Detailed description

People with schizophrenia has been known as a high risk groups for developing osteoporosis, because of lack of exercise, poor nutrition and high rate of smoking. Those with alcohol abuse may be higher risk group than one with schizophrenia without alcohol abuse, because they frequently have several medical problems such as liver dysfunction, Vitamin D deficiency, hyperparathyroidism and those medical condition increase risk for developing osteoporosis. Also alcohol itself can increase bone loss too by disturbing bone remodeling and enhancing bone fragility. To compare the prevalence of bone mineral density in patients with schizophrenia with alcohol abuse to those without alcohol problem, we will investigate BMD in large population of Korean patients with those illnesses.

Interventions

OTHERNo Intervention

No Intervention

Sponsors

Inje University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* DSM-IV diagnosis of schizophrenia * Onset of illness more than 5 years.

Exclusion criteria

* No severe Medical and endocrinological disorder

Design outcomes

Primary

MeasureTime frame
The change of bone mineral densitycross sectional and prospective

Secondary

MeasureTime frame
The effects of Smoking and antipsychotic drug on BMDCross sectional Study

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026